泽夫拉治疗 ZVRA
$11.59 +$1.06 (+10.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $11.45 -1.21%
开盘$10.59
昨收$10.53
当日区间$10.45 – $11.63
成交量1.53M
市值$689.66M
市盈率（TTM）9.5
股息率–
ZVRA 相关新闻
匹配 Zevra Therapeutics 或代码 ZVRA 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $26
- Zevra Therapeutics (ZVRA) Receives a Buy From H.C. Wainwright
- Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $35
- Guggenheim Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Cuts Target Price to $23 负面
- A Quick Look at Today's Ratings for Zevra Therapeutics(ZVRA.US), With a Forecast Between $21 to $28
- A Quick Look at Today's Ratings for Zevra Therapeutics(ZVRA.US), With a Forecast Between $24 to $28
- CCORF Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $20
- CCORF Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Cuts Target Price to $20 负面
- BTIG Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Cuts Target Price to $24 负面
- William Blair Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating
- Roth MKM Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $21
- BTIG Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $27
- A Quick Look at Today's Ratings for Zevra Therapeutics(ZVRA.US), With a Forecast Between $25 to $34
- CCORF Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $24
- Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Raises Target Price to $35 正面
暂无评论——快来第一个聊聊 ZVRA。
登录后参与讨论。